JUMPCAN(SH:600566) Sou Hu Cai Jing·2025-10-28 01:25Core Insights - Jichuan Pharmaceutical (600566.SH) reported its Q3 2025 results, revealing that as of October 27, 2025, institutional investors held a total of 559 million shares, accounting for 60.68% of the company's total equity [1] - The proportion of shares held by institutional investors decreased by 0.76 percentage points compared to the previous quarter [1] - One public fund, the Southern CSI 500 ETF, reduced its holdings during this period, while 262 public funds did not disclose their holdings, including several notable funds focused on innovative drugs and traditional Chinese medicine [1] - One pension fund, the Basic Pension Insurance Fund 808 Combination, also saw a slight decrease in its holdings compared to the previous quarter [2] Institutional Holdings - A total of nine institutional investors disclosed their holdings in Jichuan Pharmaceutical, with significant players including Jiangsu Jichuan Holding Group and Agricultural Bank of China [1] - The overall institutional holding percentage stands at 60.68%, indicating a strong institutional interest despite a slight decline [1] Public Fund Activity - The Southern CSI 500 ETF was the only public fund to report a decrease in holdings, reflecting a minor reduction in its stake [1] - A total of 262 public funds did not disclose their holdings this quarter, indicating a potential shift in investment strategies or market conditions [1] Pension Fund Overview - The Basic Pension Insurance Fund 808 Combination was the only pension fund to report a decrease in holdings, suggesting a cautious approach among pension funds in the current market environment [2]